Douglas Snyder
Vermogen: 77 522 $ op 30-06-2026
Vermogen: 77 522 $ op 30-06-2026
Douglas B. Snyder is currently Chief Legal Officer at IDEAYA Biosciences, Inc. Formerly, Mr. Snyder was Vice-President & Associate General Counsel at GSK Plc from 1999 to 2005, Secretary, Vice President & General Counsel at Eisai, Inc. from 2005 to 2012, Associate General Counsel at US Food & Drug Administration from 1994 to 1999, Secretary, Senior Vice President & General Counsel at Actelion US Holding Co. from 2012 to 2017, and Secretary, Executive VP & Chief Legal Officer at GW Pharmaceuticals Ltd. from 2017 to 2022.
Education includes undergraduate studies at Dickinson College and graduate studies at Columbus School of Law.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-03-2026 | 2.080 ( 0% ) | 77 522 $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| IDEAYA BIOSCIENCES, INC. | Algemeen Adviseur | 18-09-2024 |
| Bedrijven | Functie | Einde |
|---|---|---|
| GW PHARMACEUTICALS PLC | Algemeen Adviseur | 01-01-2022 |
Actelion US Holding Co.
Actelion US Holding Co. MiscellaneousMiscellaneous Operates as a holding company | Algemeen Adviseur | 01-01-2017 |
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Manufacturers pharmaceutical products | Algemeen Adviseur | 06-05-2012 |
| GSK PLC | Corporate Officer/Principal | 01-01-2005 |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Corporate Officer/Principal | 01-08-1999 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 8 |
|---|---|
Actelion US Holding Co.
Actelion US Holding Co. MiscellaneousMiscellaneous Operates as a holding company | Miscellaneous |
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
GW Pharmaceuticals Ltd.
GW Pharmaceuticals Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in development and commercialization of cannabinoid-based prescription medicines | Commercial Services |
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Manufacturers pharmaceutical products | Health Technology |
Dickinson College
Dickinson College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Government |
Columbus School of Law
Columbus School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IDEAYA Biosciences, Inc.
IDEAYA Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as oncology-focused precision medicine company which develops and sells cancer therapeutics | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau